|
|
| |
|
 |
Press information 4 June 2008
“Follow-up research among patients consistently shows a marginal bone level reduction of just 0.4 mm or less for Astra Tech dental implants, a performance indicator at least three times superior to the industry norm. The findings involve hundreds of individual cases and are remarkable in their consistency,” says Lyndon Cooper, Professor of Dentistry in the Department of Prosthodontics at the University of North Carolina, who has performed one of the studies. |
 |
|
|
|
|
|
3M ESPE and Astra Tech AB, a leader and innovator in the dental implant industry, announce a global partnership to provide Astra Tech’s Atlantis™ patient-specific abutments to 3M ESPE Lava™ customers. The two companies have developed an interface which will enable the Lava™ Scan ST Design System to communicate directly with Astra Tech’s Atlantis technology. |
|
|
|
|
|
|
Press release September 21, 2005
New findings from clinical studies open the door to patients with a poor prognosis for implant treatment. The research by the medical device company Astra Tech reveals a remarkable 97% success rate in difficult cases, a finding that exceeds expectations. |
|
|
|
|
|
|
Press release. July 1, 2005
Medical device company Astra Tech AB, a subsidiary of AstraZeneca PLC, is acquiring Cresco Ti Systems from its primary owners SEB Företagsinvest, Credit Suisse Innoventure Capital AG, and Banque Cantonale Vaudoise. The deal represents less than one per cent of AstraZeneca’s net assets. |
|
|
|
|
|
|
|
|
|
|
|